Teva Pharmaceutical Industries has been facing progress in share prices since the 16th of March. Today they are traded at $11.06 which is twice greater than the bottom price of the last month. Although total trading volume 4.160.224 can’t exceed the average volume of 21.895.657 the stock has seamlessly been rising within just a month. Most of the healthcare stocks could rise dramatically during the lockdown meanwhile other industries are still losing their equity values.
The company’s retained earnings have been negative since December 2016. Moreover, total stockholders’ equity is shrinking by not letting liabilities to grow. However, total assets decreased significantly. After the lockdown, Teva Pharmaceutical Industries could increase its retaining earnings because a big lesson would urge the healthcare industry to demand more vaccines and medicines.